Radiochemical and radioimmunological data of Tc-99(m)-anti-CEA labelled by two diverse methods

被引:9
|
作者
Varvarigou, AD
Archimandritis, SC
SekeriPataryas, K
Sourlingas, TG
Sivolapenko, G
Paschali, E
机构
[1] Institute of Radiodiagnostics, Natl. Ctr. Sci. Res. 'Demokritos', Aghia Paraskevi Attikis 15310
[2] 'Encephalos' Diagnostics T., Athens
关键词
D O I
10.1097/00006231-199601000-00014
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The aim of this study was to make a comparative evaluation of a direct and an indirect method for the labelling of anti-CEA with technetium-99m (Tc-99(m)). With the direct method, disulphide bridges were cleaved by the use of 2-mercaptoethanol as reductant, whereas with the indirect method, the antibody was coupled to 2-iminothiolane. In both cases, a preformed intermediate chelate was used for Tc-99(m) exchange. The radiochemical and radiobiological behaviour of the Tc-99(m)-labelled species were studied. Furthermore, the influence of the labelling systems on the integrity of monoclonal antibodies, as well as the ability of Tc-99(m)-anti-CEA to tag onto human cancer cells, was investigated for the two labelling systems. Both methods showed a high labelling yield and resulted in immunoreactive and stable derivatives. However, detailed electrophoretical and radiochemical data, as well as the cysteine challenge trial, indicated relatively greater stability for the 2-mercaptoethanol reduction procedure.
引用
收藏
页码:80 / 88
页数:9
相关论文
共 50 条
  • [1] Immunoscintigraphy with TC-99M labelled Anti-CEA Fragments in Patients with Colorectal Carcinoma
    Lacic, M.
    Lukac, J.
    Lacic, M.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S288 - S288
  • [2] RADIOIMMUNOSCINTIGRAPHY OF COLORECTAL-CARCINOMA WITH A TC-99(M)-LABELED ANTI-CEA MONOCLONAL-ANTIBODY (BW 431/26)
    MUXI, A
    SOLA, M
    BASSA, P
    PONS, F
    GARCIA, A
    MORAGAS, M
    LOMENA, F
    HERRANZ, R
    FERNANDEZ, R
    TRIAS, M
    SETOAIN, J
    NUCLEAR MEDICINE COMMUNICATIONS, 1992, 13 (04) : 261 - 270
  • [3] COMPARISON OF 4 ALTERNATIVE RADIOCHEMICAL PURITY TESTING METHODS FOR TC-99(M)-SESTAMIBI
    HUNG, JC
    WILSON, ME
    GEBHARD, MW
    GIBBONS, RJ
    NUCLEAR MEDICINE COMMUNICATIONS, 1995, 16 (02) : 99 - 104
  • [4] Radioimmunoguided surgery with Tc-99m-labeled anti-CEA in rectal cancer
    Franchella, C
    Fabrizio, G
    Monaco, B
    Beato, E
    Fiore, A
    XXIII NATIONAL CONGRESS SOCIETA ITALIANA DI CHIRURGIA ONCOLOGICA, 1999, : 605 - 609
  • [5] Comparison of radiochemical purity control methods for Tc-99(m) radiopharmaceuticals used in hospital radiopharmacies
    Mallol, J
    Bonino, C
    NUCLEAR MEDICINE COMMUNICATIONS, 1997, 18 (05) : 419 - 422
  • [6] PHARMACOKINETICS OF THE FO23C5 ANTI-CEA ANTIBODY FRAGMENT LABELED WITH TC-99(M) AND IN-111 - A COMPARISON IN PATIENTS
    HNATOWICH, DJ
    MARDIROSSIAN, G
    RUSCKOWSKI, M
    ROY, S
    BUSHE, H
    GRIFFIN, TW
    BRILL, AB
    NUCLEAR MEDICINE COMMUNICATIONS, 1993, 14 (01) : 52 - 63
  • [7] In vitro and in vivo comparison of binding of 99m-Tc-labeled anti-CEA MAb F33-104 with 99m-Tc-labeled anti-CEA MAb BW431/26
    Watanabe, N
    Oriuchi, N
    Sugiyama, S
    Kuroki, M
    Matsuoka, Y
    Tanada, S
    Murata, H
    Inoue, T
    Sasaki, Y
    NUKLEARMEDIZIN, 1999, 38 (04) : 115 - 119
  • [8] RADIOCHEMICAL AND RADIOIMMUNOLOGICAL QUALITY STUDIES OF TC-99M-LABELLED HUMAN-SERUM ALBUMIN PRODUCED BY 2 COMMERCIAL KITS
    PAUWELS, EKJ
    FEITSMA, RIJ
    VANLANGEVELDE, A
    RADIOCHIMICA ACTA, 1977, 24 (04) : 211 - 213
  • [9] RADIOIMMUNOSCINTIGRAPHY OF NONSMALL CELL LUNG-CANCER USING TC-99M ANTI-CEA FAB' (IMMURAID CEA)
    FIG, LM
    KRAMER, EL
    HARWOOD, SJ
    HUGHES, L
    PINSKY, CM
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P217 - P217